237 related articles for article (PubMed ID: 30190655)
1. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
[TBL] [Abstract][Full Text] [Related]
2. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
[TBL] [Abstract][Full Text] [Related]
4. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
5. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
Aamir M; Khan JA; Shakeel F; Asim SM
Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
7. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.
Shuib W; Wu XY; Xiao F
World J Pediatr; 2021 Aug; 17(4):341-354. PubMed ID: 34080130
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoepidemiological evaluation of off label and unlicensed prescription in pediatric intensive care units at tertiary care hospitals of Peshawar, Pakistan.
Aamir M; Abid Shah M; Naheed Kauser T; Khan N; Mehmood I; Ali Khan J; Iqbal W
Pak J Pharm Sci; 2023 Jan; 36(1):81-87. PubMed ID: 36967500
[TBL] [Abstract][Full Text] [Related]
9. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
Tukayo BLA; Sunderland B; Parsons R; Czarniak P
PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
[TBL] [Abstract][Full Text] [Related]
11. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
12. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
[TBL] [Abstract][Full Text] [Related]
13. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
[TBL] [Abstract][Full Text] [Related]
14. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.
Palčevski G; Skočibušić N; Vlahović-Palčevski V
Eur J Clin Pharmacol; 2012 Jul; 68(7):1073-7. PubMed ID: 22307225
[TBL] [Abstract][Full Text] [Related]
15. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
17. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
Gavrilov V; Lifshitz M; Levy J; Gorodischer R
Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
[TBL] [Abstract][Full Text] [Related]
18. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
19. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
20. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
